Tandem Diabetes Care | TNDM - Trade Creditors


Tandem Diabetes Care reported $47.07M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Abbott USD 4.12B 183M Sep/2025
Accuray USD 42.4M 8.37M Sep/2025
Align Technology USD 121.45M 4.1M Dec/2025
AtriCure USD 78.4M 3.56M Dec/2025
Baxter International USD 999M 46M Dec/2025
Becton, Dickinson and Co. USD 6.14B 4.16B Dec/2025
Boston Scientific USD 1.14B 142M Dec/2025
Cooper Companies USD 300.4M 44.5M Sep/2025
Dexcom USD 1.83B 1.38B Dec/2025
Edwards Lifesciences USD 165M 94.2M Sep/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Globus Medical USD 98.85M 11.62M Dec/2025
ICU Medical USD 154.37M 17.38M Dec/2025
Inogen USD 21.22M 684K Sep/2025
Insulet USD 75M 26.8M Dec/2025
Integra LifeSciences USD 92.3M 530K Sep/2025
Intuitive Surgical USD 1.92B 179.7M Dec/2025
J&J USD 11.99B 2.37B Dec/2025
Masimo USD 117.9M 17.8M Sep/2025
Medtronic USD 2.58B 26M Sep/2025
Merit Medical Systems USD 60.55M 4.19M Dec/2025
Orthofix International USD 50.46M 5.36M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Stryker USD 1.5B 56M Sep/2025
Tandem Diabetes Care USD 47.07M 414K Dec/2025
Teleflex USD 165.91M 8.35M Sep/2025
Zimmer Biomet Holdings USD 303M 12.3M Dec/2025